## Summary

This paper proposes a three-stage deep learning pipeline for assessing hip implant loosening from X-ray images: (1) an image-quality fitness check, (2) segmentation of the implant into 10 anatomical zones (7 Gruen + 3 Charnley) plus background, and (3) zone-wise radiolucency classification (control/loose/not visible). The authors also contribute zone-level annotations to the existing Rahman et al. (2022) dataset. Reported results show 0.95 Dice for segmentation and 98% loosening accuracy on a 57-image test set, plus 0.92 Dice and 93% accuracy on 38 blind clinical images.

## Strengths

- **Blind testing on an external clinical dataset provides genuine validity evidence.** The evaluation on 38 completely unseen THR images from an independent clinical source (Section 4.3, lines 175–177) achieving 0.92 Dice for segmentation and 0.93 accuracy for loosening detection goes beyond typical held-out splits and suggests meaningful generalization.

- **Zone-level annotation contribution fills a genuine gap.** The paper creates what it states is the first open-source dataset with zone-wise (Gruen and Charnley) segmentation and loosening annotations for the Rahman et al. (2022) dataset (Section 3.1, line 53). This is a concrete resource contribution that enables clinically relevant zone-level analysis.

- **The fitness-check stage (Stage 1) and "not visible" zone class (Stage 3) are practically motivated design choices.** Rejecting poor-quality X-rays before downstream analysis (Section 3.2.1) and modeling partially/fully invisible zones as a separate class rather than misclassifying them (Section 3.2.3, line 105) address real clinical failure modes.

- **Loss ablation is reported.** The paper shows dice loss alone gives 87% segmentation accuracy versus 95% for combined cross-entropy + dice loss (Section 4.2, line 136), providing evidence for a specific design choice.

## Weaknesses

### Fatal
None.

### Major

- **Ambiguous Stage 3 method description: the core of the claimed contribution cannot be fully evaluated.** Section 3.2.3 (line 105) states the loosening detection network takes "zonal loosening information from the created Excel" as an input — where this Excel file (described in Section 3.1, line 53) contains the ground-truth zone-level labels (control/loose/not visible). If ground-truth labels are fed as inference-time features, the setup is circular. If they are only used as training targets, the text describing "three inputs" is misleading. The paper does not explain how Stage 3 would operate on a new X-ray where no Excel ground truth exists, nor does it clarify the actual inference-time input schema. The blind test results suggest the system does work without the Excel, so this is likely just poor phrasing, but the ambiguity as written prevents proper evaluation.

- **Comparisons against prior work (Table 3) are fundamentally unfair.** The baselines (Rahman et al., Lawrence et al.) were trained on the original dataset's image-level control/loose labels. The proposed method uses zone-level manual annotations (created by the authors) as intermediate supervision — a strictly richer training signal. A meaningful comparison would either (a) train the baselines on the same zone-level annotations, or (b) ablate the zone-level supervision from the proposed method and compare at the image level. As presented, the comparison conflates supervision advantage with architectural advantage.

- **The dataset is too small to support the strong quantitative claims, and no uncertainty is reported.** The segmentation network (encoder-decoder with up to 1024 filters) is trained on 130 images for 300 epochs. The loosening classifier reports 98% accuracy (23 TP, 33 TN, 1 FN, 0 FP) on a 57-image test set. No confidence intervals, per-fold variances, or standard deviations are reported anywhere (Section 4). The blind test degradation (0.95→0.92 Dice, 98%→93% accuracy) suggests meaningful variance that is not analyzed. Stage 1's fitness check is trained on only 19 positive examples, too few for a reliable binary classifier even with augmentation.

- **Internal inconsistency: confusion matrix contradicts the 5-fold CV claim.** The paper states "the reported results are the average values of this cross-validation" (Section 4, line 122), yet the confusion matrix (Table 2, lines 155–156) shows integer counts (23+33+1+0=57) that exactly match the 70:30 test split size — consistent with a single train/test run, not averaged results from 5 folds. This undermines the paper's claim about cross-validation.

### Minor

- **No inter-annotator reliability reported.** All annotations were performed by a single orthopedic surgeon (Section 3.1, line 53). For subjective clinical judgments about radiolucency boundaries and zone visibility, this is a notable methodological gap.

- **No error analysis or limitations discussion.** The paper reports near-perfect results but does not examine the single false negative, discuss failure cases, analyze what types of radiolucency the system handles poorly, or consider diversity of implant types, patient anatomies, or imaging conditions. For a clinical application paper, this is a significant omission.

- **Limited ablation studies.** The only ablation is dice loss alone vs. combined loss (Section 4.2, line 136). No other design choices are ablated: skip connections, the exponential logarithmic loss in Stage 3, freezing vs. fine-tuning Stage 2 weights, the "not visible" class, or the multi-stage design itself.

- **Stage 3 architecture is under-specified.** The support network is described as "flatten → dense 64 → 3-class softmax" (line 107), but it is unclear how this single 3-class output supports zone-wise predictions for 10 zones, how the three claimed inputs are fused, or whether the base network weights are frozen or fine-tuned.

### Trivial

- None of significance that survive the filtering discipline.

## Nice-to-Haves

- Reporting per-zone Dice and classification metrics with confidence intervals or standard deviations across 5 folds.
- An inter-annotator agreement study on a subset of images.
- Clarifying the blind test dataset's provenance, annotation process, and whether the same or a different expert labeled it.
- Stating whether code/trained models will be released.

## Removed Points

The following points from the inputs were filtered or restructured:

- *"GradCAM is designed for classification networks, not segmentation"* — Factually incorrect; GradCAM works with any CNN by targeting a specific output class. Removed.
- *"GradCAM color convention is wrong"* — The paper explicitly states its own custom color mapping (blue=most significant, red=least). No error. Removed.
- *"No ablation studies at all"* — Overstated; one loss ablation is reported. Downgraded to "limited ablation."
- *"Stage 3 is incoherent/invalid"* (as fatal) — The blind test validates the system works, so the method is not inherently invalid; the description is simply ambiguous. Downgraded to major.
- *"Missing IRB approval"* — Removed per hard rules; this is a reasonable suggestion but not a standard evaluation criterion for technical ML venue review.
- *"19 positive examples is too few for reliable binary classifier"* — Merged into the "dataset too small" major weakness rather than as a standalone point.
- *"Reproducibility: no code release"* — Removed per hard rules (this is a nice-to-have, not a weakness against a conference submission).
- Several generic "evaluation lacks rigor" framings from the Harsh Critic — Specific concrete anchors extracted and retained; unsupported generalities removed.

## Novel Insights

None beyond the paper's own contributions. The reviews did not surface an unarticulated insight present in the paper.

## Suggestions

1. **Clarify Stage 3 operation.** Explicitly state what information flows into the loosening detection network at inference time (input image + Stage 2 segmentation mask, with the Excel providing only training targets). Describe how the support network produces zone-wise predictions for 10 zones from what appears to be a single 3-class softmax head.

2. **Make comparisons fair.** Either train baselines with zone-level annotations, or ablate the zone-level supervision from the proposed method and compare at the image level. Report what supervision each method receives.

3. **Add statistical uncertainty.** Clarify the 5-fold CV reporting and add confidence intervals or per-fold variance for all key metrics.

4. **Add dedicated limitations and error analysis sections.** Discuss the small dataset, single-annotator ground truth, potential confounders, and the blind test degradation.

5. **Expand ablation studies.** At minimum, ablate: (a) Stage 3 with vs. without pre-trained Stage 2 weights, (b) exponential logarithmic loss vs. standard combined loss, (c) the "not visible" class vs. binary classification.

## Score and Decision

**Score:** 4.5

**Decision:** Reject

**Rationale:** The paper targets a clinically meaningful problem and contributes useful zone-level annotations. However, for a top-tier venue, the experimental validation is not commensurate with the claims. The critical ambiguity in the Stage 3 description, the unfair comparisons against prior work, the small dataset with no statistical uncertainty quantification, the internal inconsistency in reporting (confusion matrix vs. 5-fold CV), and the near-complete absence of error analysis or adequate ablation studies collectively prevent acceptance. The blind test provides some evidence of robustness, but the methodological validation is too weak for ICLR.

MY FINAL SCORE: <score>4.5</score>
MY FINAL DECISION: <decision>Reject</decision>